0001628280-25-052957
SEC filingNutex Health holds $96.7M cash, $68.8M accrued arbitration, $24.2M stock comp liability, and authorized $25M buyback.
As of June 30, 2025, Nutex Health held $96.7M in cash and equivalents, up from $40.6M at year-end 2024, primarily driven by operations. Total debt stood at $47.8M, including $7.9M in lines of credit and $18.9M current portion of long-term debt. The company's liquidity is partially offset by a significant $68.8M in accrued arbitration expenses related to the Independent Dispute Resolution process under the No Surprises Act. Additionally, accrued stock-based compensation of $24.2M represents obligations for under-construction hospitals, measured at fair value using Monte Carlo simulation.
The most material commitment is the liability for additional stock issuances to former owners of ramping and under-construction hospitals. As of June 30, 2025, $24.2M is recorded for these obligations, with a further estimated $25.4M in compensation expense expected for hospitals with measurement periods ending after June 30, 2025. Other commitments include $1.9M outstanding for capital contributions to facilities under construction. Post-period end, the company entered into an asset purchase agreement totaling $8.0M, comprising debt, deferred payment, and subsidiary equity. The company also faces litigation from former owners disputing the calculation of stock issuance, which could have a material adverse effect.
On August 14, 2025, the board authorized a $25.0M stock repurchase program to offset dilution from merger-related issuances. During the six months ended June 30, 2025, the company had net debt issuance of $6.4M, with $4.9M in proceeds and $5.7M in repayments. Capital expenditures were modest at $0.8M (0.18% of sales). No dividends were paid. The company also issued 2,027 shares under the Employee Stock Purchase Plan and converted $0.5M of convertible debt into 17,874 shares.
The hospital division dominates, generating $440.2M (96.6%) of total $455.8M revenue for the six months, a 245% YoY increase. Segment income before taxes was $224.4M, implying a 51% operating margin. The population health management division contributed $15.5M revenue, down 2.4% YoY, with near-breakeven income. The real estate division had no external revenue and an operating loss of $0.2M. All operations are domestic, with 24 hospital facilities across 11 states. The company also consolidates variable interest entities including physician LLCs and real estate entities.